iRadimed Corporation
IRMDMedical Devices
$76.68−10.57%As of Oct 30vs prior close
- Market cap
- $980.5M
- P/E (TTM)
- 40.9×
- From 52W high
- −26.71%
- EPS (LTM)
- $1.87
- Revenue (LTM)
- $89.3M
- Net margin
- 26.85%
- Dividend yield
- 1.00%
Nomior Score
80
Fortified DefenderSpeculativeTop 2% of the scored universe
Growth62
Quality88
Value56
Momentum60
Resilience75
Growth
+11.10%revenue a year over 9 fiscal years
FY16 $32.5MLTM $89.3M
Connections
Revenue to profitQ3 FY26
27% of revenue became net profit, up 1 pt on a year.
Latest resultsthird quarter 2026
- Net income
- $6.5 million
- Diluted EPS
- $0.51
- Adjusted EPS
- $0.55
- Revenue outlook
- $91.6 million to $93.1 million
- EPS outlook
- $1.90 to $1.94
Revenue and profit rose strongly in the quarter, with record revenue driven by the launch of the new MR IV pump and record bookings. Gross margin improved sequentially as manufacturing efficiencies were realized. Management expects a strong finish to the year and revised its full-year guidance.
Who owns it
2funds